Remdesivir: One of the Few Proven Treatments for COVID-19 Patients
In April 2020, Gilead Sciences raised its annual sales outlook to include projected revenue from remdesivir, an antiviral drug showing early promise in treating hospitalized COVID-19 patients, marking one of ... Read More